Want to join the conversation?
Pharmacy benefit manager $ESRX reported a 33% jump in 4Q15 earnings driven by lower costs and expenses despite a decline in revenue. Net income rose to $773.5MM or $1.13 per share from $581.8MM or $0.79 per share last year. Revenue slid to $26.18Bil from $26.31Bil. Adjusted EPS increased by 12% to $1.56.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.